Certain Equity Shares of Concord Biotech Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2024. These Equity Shares will be under lockup for 186 days starting from 9-AUG-2023 to 11-FEB-2024.

Details:
In accordance with Regulation 14 and Regulation 16(1) of the SEBI ICDR Regulations, an aggregate of 20% of the fully diluted post-Offer Equity Share capital of our Company held by our Promoters, shall be locked in for a period of 18 months, or such other period as prescribed under the SEBI ICDR Regulations, as minimum promoters? contribution from the date of Allotment (?Promoters? Contribution?), and our Promoters? shareholding in excess of 20% of the post-Offer equity share capital shall be locked in for a period of six months from the date of Allotment.

In addition to 20% of the fully diluted post-Offer shareholding of our Company held by our Promoters and locked-in for a period of 18 months as specified above, in terms of the SEBI ICDR Regulations, the entire pre-Offer Equity Share capital of our Company will be locked-in for a period of six months from the date of Allotment, including any unsubscribed portion of the Offer for Sale, and any other categories of shareholders exempted under Regulation 17 of the SEBI ICDR Regulations, as applicable.

The entire pre-offer equity share capital of the company will be locked-in for a period of six months from the date of allotment, including any unsubscribed portion of the offer for sale, and any other categories of shareholders exempted under Regulation 17 of the SEBI ICDR Regulations, as applicable.